Representatives from leading corporates such as Boston Scientific, DePuy, Hospira and Philips Healthcare are set to gather in March to share best practice alongside more than fifteen fellow executives for two days of focused debate and networking at the European Sales and Marketing Summit, a two-day business conference organised by MDDexec on 17th and 18th March 2010, in London...

The Pharmacovigilance Legislation Will Come into Effect in July As the European Medicines Agency's new PV (pharmacovigilance) Legislation implementation date of July 2012 approaches, US and European pharmaceutical and biotech companies need to ask themselves if they are ready for the changes that lie ahead, says Paul Beninger, ...

Chinese officials are in the final stages of approving the use of the country's very first non-animal test method for cosmetics ingredients, thanks to guidance from scientists funded by PETA. The 3T3 Neutral Red Uptake Phototoxicity Assay, which tests chemicals for their potential toxicity when they come into contact with ...

Drug dispensing robots designed to quickly prepare intravenous medications in a sterile environment can harbor dangerous bacteria, according to a report in Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. During a routine screening in 2010, personnel at Wake Forest Baptist Medical Center ...

Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine. Laboratory mice, ...

A discovery published in the March 25 issue of Nature Chemical Biology reveals that biomolecular engineers from Cornell University have discovered that Escherichia coli, a bacteria that is considered to be a severe threat in terms of food safety by restaurateurs, grocers and consumers, is in fact, a friendly bacteria. ...

The traditional way of making medicines from ingredients mixed together in a factory may be joined by a new approach in which doctors administer the ingredients for a medicine separately to patients, and the ingredients combine to produce the medicine inside patients' bodies. That's one promise from an emerging new ...

UAB researchers developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as "bacteria inclusion bodies", stable insoluble nanoparticles which are found normally in recombinant bacteria. Even though these inclusion bodies traditionally have been an obstacle in the industrial production of soluble enzymes and biodrugs, they ...